Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
CENTENARIAN RATES AND LIFE EXPECTANCY RELATED TO THE DEATH RATES OF MULTIPLE SCLEROSIS, ASTHMA AND RHEUMATOID ARTHRITIS AND THE INCIDENCE OF TYPE 1 DIABETES IN CHILDREN.
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program.
Identification of a unique TGF-β-dependent molecular and functional signature in microglia.
Adverse socioeconomic position during the life course is associated with multiple sclerosis.
Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients.
Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis.
Outcome Measures for Individuals With Multiple Sclerosis: Recommendations From the American Physical Therapy Association Neurology Section Task Force.
Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Anorectal dysfunction in multiple sclerosis: a systematic review.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
Idiopathic Acute Transverse Myelitis in Children: A Retrospective Series.
Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.

Pages